China Official Says Taking Steps To Expand Availability Of Key Drugs
This article was originally published in PharmAsia News
Executive Summary
China's vice premier said steps would be taken beginning as early as this year to reform the nation's healthcare system, including the availability and handling of medicines. Vice Premier Li Keqiang said at a meeting on the subject that one intent is to ensure affordable access to crucial drugs, beginning this year in government hospitals and clinics at the grassroots level. He said the government also plans to separate treatment services from medicine sales in government hospitals in 16 cities this year and to increase reimbursements for medical treatments for severe diseases. (Click here for more)
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.